He traded New York finance for Stanford, then built the lab software that most of the legal cannabis industry depends on and almost no consumer has ever heard of.
Most founders in cannabis wanted to sell you something you could hold, smoke, or Instagram. Steve Albarran wanted to sell you certainty about what was actually in it. That is a harder pitch, and a far stickier one, which is roughly the point of his entire career.
Albarran grew up in Mexico City in a family where entrepreneurship was practically the house dialect. Both his parents ran businesses. So did both of his grandfathers. When you are raised among people who sign the front of the paycheck rather than the back, a salaried life tends to feel like a costume you are trying on rather than a body you were born into.
He wore the costume well for a while. After a finance degree from Bentley University in 2007, he spent close to nine years in New York doing the things ambitious finance graduates do: mergers-and-acquisitions banking at Lehman Brothers and later Sawaya Partners, followed by a stint running his own show at Left Lane Capital Partners, a growth-equity firm pointed at health and wellness. One of his bets there was Health Warrior, a superfood snack brand that grew fast enough to make the resume look tidy. It was a respectable arc. It was also, he seems to have decided, not quite the thing.
So he went to Stanford Graduate School of Business as a Sloan Fellow, which is the polite adult way of saying he pressed pause to figure out what he actually wanted to build. What he found was a co-founder, Tony Lewis, and a plant that most of his peers were too nervous to touch.
The nervousness was understandable, and personal. Albarran had grown up under the full weight of Reagan-era anti-drug messaging and carried a low hum of childhood guilt about cannabis. But as Colorado and Washington legalized, and as he did the reading, the guilt curdled into curiosity and then conviction. There were social justice arguments. There were economic arguments. There were health arguments. And there was one argument that hit closer to home than any policy paper: the money.
“I loved the idea of legal ethical businesses taking money from bad guys with guns in Mexico.”
Albarran framed the industry's central weakness plainly: there was very little transparency into what was being made, who made it, and what it was made of. In an ordinary market that gap gets filled by brands and regulators. In cannabis, both were young, fragmented, and legally hemmed in.
Confident Cannabis attacked the gap from the least glamorous angle possible: the testing lab. Its software, a laboratory information management system, is what third-party labs install to track samples and deliver results while staying compliant with a patchwork of local rules. Own the results, and you quietly become the layer everyone else has to trust.
Illustrative reach across the legal cannabis supply chain. Precise share disclosed publicly only for testing labs (60%+).
Graduates with a finance degree, following a family line of business owners out of Mexico City.
M&A banking at Lehman Brothers and Sawaya Partners, then his own firm, Left Lane Capital.
Joins as a Sloan Fellow, meets co-founder Tony Lewis, and sketches out Confident Cannabis.
Co-founds the company and goes through Y Combinator's S15 batch.
Reaches profitability in September, then rebrands to Confident LIMS to grow beyond cannabis.
Leads expansion into food, agriculture and environmental testing; member of the NCLC.
“Startups are hard. Cannabis is hard. Cannabis startups are really hard.”
“Foster a vibrant and sustainable ecosystem in which every ethical cannabis business thrives.”
“The rails upon which the global cannabis industry runs.”
“I loved the idea of legal ethical businesses taking money from bad guys with guns in Mexico.”
Here is the absurdist punchline of building a cannabis company that never touches cannabis: Confident Cannabis lost three bank accounts anyway. Because the plant sits on the federal Schedule I list, and because tax code section 280E treats the whole neighborhood as guilty by association, even a pure software vendor gets treated like a suspect.
Albarran kept building. It is the sort of obstacle that filters out founders who wanted a clean story and rewards the ones who were in it for the mission. He was clearly the second kind.
There is a neat symmetry to his private life. Albarran is married to a chef and learned to cook through her and, less romantically, the Food Network. He favors minimalist cooking and Italian wines, with a soft spot for Valpolicella.
A man who built a company obsessed with knowing exactly what is in what you consume, married to someone who does the same at the stove. The through-line is not an accident.
The 2022 rebrand from Confident Cannabis to Confident LIMS was a statement of ambition. Having become critical infrastructure for one regulated industry, Albarran wants the same for the others: food and beverage, agriculture, environmental and industrial chemistry. The plant was the wedge. The plan is to be the trusted data layer for anyone who has to prove what is in something.